333 related articles for article (PubMed ID: 21695652)
1. Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders.
Xu Y; Zhang HT; O'Donnell JM
Handb Exp Pharmacol; 2011; (204):447-85. PubMed ID: 21695652
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
3. Overview of PDEs and their regulation.
Omori K; Kotera J
Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970
[TBL] [Abstract][Full Text] [Related]
4. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotide phosphodiesterases.
Essayan DM
J Allergy Clin Immunol; 2001 Nov; 108(5):671-80. PubMed ID: 11692087
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterases in the central nervous system.
Kleppisch T
Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
[TBL] [Abstract][Full Text] [Related]
7. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Beierwaltes WH
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer with phosphodiesterase inhibitors.
Savai R; Pullamsetti SS; Banat GA; Weissmann N; Ghofrani HA; Grimminger F; Schermuly RT
Expert Opin Investig Drugs; 2010 Jan; 19(1):117-31. PubMed ID: 20001559
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
Lugnier C
Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseases.
Wang ZZ; Zhang Y; Zhang HT; Li YF
Curr Pharm Des; 2015; 21(3):303-16. PubMed ID: 25159069
[TBL] [Abstract][Full Text] [Related]
11. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
Simmons MA; Hartzell HC
Mol Pharmacol; 1988 Jun; 33(6):664-71. PubMed ID: 2454387
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.
Bender AT; Beavo JA
Pharmacol Rev; 2006 Sep; 58(3):488-520. PubMed ID: 16968949
[TBL] [Abstract][Full Text] [Related]
13. [Phosphodiesterase regulation of cardiovascular functions].
Li L; He Q; Gao YS
Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):100-6. PubMed ID: 21416994
[TBL] [Abstract][Full Text] [Related]
14. Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
Ahlström M; Lamberg-Allardt C
J Bone Miner Res; 1997 Feb; 12(2):172-8. PubMed ID: 9041048
[TBL] [Abstract][Full Text] [Related]
15. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
Kokkonen K; Kass DA
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
[TBL] [Abstract][Full Text] [Related]
16. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
Gupta R; Kumar G; Kumar RS
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
[TBL] [Abstract][Full Text] [Related]
17. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
Baxendale RW; Fraser LR
Mol Reprod Dev; 2005 Aug; 71(4):495-508. PubMed ID: 15856425
[TBL] [Abstract][Full Text] [Related]
18. Improving memory: a role for phosphodiesterases.
Blokland A; Schreiber R; Prickaerts J
Curr Pharm Des; 2006; 12(20):2511-23. PubMed ID: 16842174
[TBL] [Abstract][Full Text] [Related]
19. Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence.
Wen RT; Liang JH; Zhang HT
Adv Neurobiol; 2017; 17():413-444. PubMed ID: 28956341
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
